Overall, these results further validated the data from metabolomics, demonstrating that down-regulation of nucleolin resulted in glucose metabolism disorder during endotoxemia-induced myocardial injury, while over-expression of nucleolin had the potential to exert a corresponding protective effect. This evidence concerns the gene NUCLEOLIN and glucose metabolism disease.